Skip to content

Surgically Targeted Radiation Therapy (STaRT) for Brain Tumors

Contact Us

healthcare PROVIDERS site

Treatment Considerations

Menu

Home
Patient Navigator
Find a Center
FAQ
Education
Events
Contact Us

Contact Us

Sign up to receive important updates on GammaTile Therapy, upcoming events, and new treatment centers around the country.

Patient Navigator
Find a Center
FAQ
Education
Events
Resources
Contact

CONNECT WITH US

TREATMENT CONSIDERATIONS

GammaTile® is indicated as a treatment for patients with newly diagnosed malignant intracranial neoplasms and patients with recurrent intracranial neoplasms. The potential for, and symptoms of, adverse events related to radiation exposure vary depending on the radiosensitivity of the exposed tissue, the amount of radiation delivered, and the placement of GammaTile(s). Serious side effects related to GammaTile Therapy are rare, and may include radiation brain changes including necrosis. GammaTile Therapy should not be used for patients with known history of hypersensitivity to bovine-derived materials. Possible complications can occur with any neurosurgical procedure, including cerebrospinal fluid leaks, infection, delayed hemorrhage, and adhesion formation.

IMPROVING THE LIVES OF PATIENTS WITH BRAIN TUMORS

©2023 GT Medical Technologies, Inc. I All rights reserved | Privacy Policy | Terms of Use